Literature DB >> 28719916

Pediatric Short Bowel Syndrome: Predicting Four-Year Outcome after Massive Neonatal Resection.

Teresa Capriati1, Daniela Giorgio1, Fabio Fusaro2, Manila Candusso3, Paolo Schingo4, Tamara Caldaro5, Francesca Laureti1, Domenica Elia1, Antonella Diamanti1.   

Abstract

OBJECTIVES: The aim of this study was to ascertain predictors of survival, liver disease (LD), and enteral autonomy 48 months after resection in neonatal short bowel syndrome (SBS) patients with residual small bowel length (SBL) ≤40 cm. PATIENTS AND METHODS: Medical records of all SBS patients followed up between 1996 and 2016 were retrospectively reviewed. Survival rate, prevalence of LD, and of enteral autonomy were evaluated.
RESULTS: Forty-seven patients were included, and 43 were still alive at the end of the study period, with cumulative 48-month survival of 91.5%. Twenty-one (45%) patients developed LD, all within the first 6 months. On the final follow-up visit, three (6%) patients were still jaundiced and progressed toward end-stage LD. LD prevalence was higher in patients with recurrent bloodstream infections (odds ratio [OR] 5.4, 95% confidence interval [CI] 1.5-19.3). Of the 43 surviving patients, 22 (51%) had enteral autonomy 48 months after resection. The probability of weaning off parenteral nutrition (PN) was strongly correlated with the remaining SBL.
CONCLUSION: Survival of patients who have undergone neonatal massive small bowel resection has improved in recent years. Multidisciplinary strategies can improve the course of LD, but not the probability of weaning off PN, which seems to be strongly dependent on the anatomical profile of residual bowel. Therefore, the primary surgical approach should be as conservative as possible to gain even small amounts of intestinal length, which may be crucial in promoting intestinal adaptation. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28719916     DOI: 10.1055/s-0037-1604113

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  5 in total

Review 1.  Nutritional and pharmacological strategy in children with short bowel syndrome.

Authors:  Michael E Höllwarth; Valeria Solari
Journal:  Pediatr Surg Int       Date:  2021-01-03       Impact factor: 1.827

2.  Long-term outcomes of various pediatric short bowel syndrome in China.

Authors:  Tian Zhang; Haixia Feng; Yi Cao; Yijing Tao; Lina Lu; Weihui Yan; Fang Li; Ying Wang; Wei Cai
Journal:  Pediatr Surg Int       Date:  2021-01-04       Impact factor: 1.827

Review 3.  To Wean or Not to Wean: The Role of Autologous Reconstructive Surgery in the Natural History of Pediatric Short Bowel Syndrome on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP).

Authors:  Teresa Capriati; Antonella Mosca; Tommaso Alterio; Maria Immacolata Spagnuolo; Paolo Gandullia; Antonella Lezo; Paolo Lionetti; Lorenzo D'Antiga; Fabio Fusaro; Antonella Diamanti
Journal:  Nutrients       Date:  2020-07-18       Impact factor: 5.717

4.  Pediatric Chronic Intestinal Failure in Italy: Report from the 2016 Survey on Behalf of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP).

Authors:  Antonella Diamanti; Teresa Capriati; Paolo Gandullia; Grazia Di Leo; Antonella Lezo; Laura Lacitignola; Maria Immacolata Spagnuolo; Simona Gatti; Lorenzo D'Antiga; Giovanna Verlato; Paola Roggero; Sergio Amarri; Maria Elisabetta Baldassarre; Francesco Cirillo; Domenica Elia; Renata Boldrini; Angelo Campanozzi; Carlo Catassi; Marina Aloi; Claudio Romano; Manila Candusso; Nicola Cecchi; Tommaso Bellini; Elaine Tyndall; Fabio Fusaro; Tamara Caldaro; Daniele Alberti; Piergiorgio Gamba; Mario Lima; Pietro Bagolan; Jean De Ville de Goyet; Luigi Dall'Oglio; Marco Spada; Francesca Grandi
Journal:  Nutrients       Date:  2017-11-05       Impact factor: 5.717

5.  Surgeon's perspective on short bowel syndrome: Where are we?

Authors:  Ignazio R Marino; Augusto Lauro
Journal:  World J Transplant       Date:  2018-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.